14 results on '"De Felice, M."'
Search Results
2. Growth inhibition as a consequence of antagonism between related amino acids: effect of valine in Escherichia coli K-12
- Author
-
De Felice, M, Levinthal, M, Iaccarino, M, and Guardiola, J
- Published
- 1979
- Full Text
- View/download PDF
3. IlvHI locus of Salmonella typhimurium
- Author
-
Squires, C H, De Felice, M, Lago, C T, and Calvo, J M
- Abstract
In Escherichia coli K-12, the ilvHI locus codes for one of two acetohydroxy acid synthase isoenzymes. A region of the Salmonella typhimurium genome adjacent to the leucine operon was cloned on plasmid pBR322, yielding plasmids pCV47 and pCV49 (a shortened version of pCV47). This region contains DNA homologous to the E. coli ilvHI locus, as judged by hybridization experiments. Plasmid pCV47 did not confer isoleucine-valine prototrophy upon either E. coli or S. typhimurium strains lacking acetohydroxy acid synthase activity, suggesting that S. typhimurium lacks a functional ilvHI locus. However, isoleucine-valine prototrophs were readily isolated from such strains after mutagenesis with nitrosoguanidine. In one case we found that the Ilv+ phenotype resulted from an alteration in bacterial DNA on the plasmid (new plasmid designated pCV50). Furthermore, a new acetohydroxy acid synthase activity was observed in Ilv+ revertants; this enzyme was similar to E. coli acetohydroxy acid synthase III in its lack of activity at low pH. This new activity was correlated with the appearance in minicells of a new polypeptide having an approximate molecular weight of 61,000. Strains carrying either pCV49 or pCV50 produced a substantial amount of ilvHI-specific mRNA. These results, together with results from other laboratories, suggest that S. typhimurium has functional ilvB and ilvG genes and a cryptic ilvHI locus. E. coli K-12, on the other hand, has functional ilvB and ilvHI genes and a cryptic ilvG locus.
- Published
- 1983
- Full Text
- View/download PDF
4. Proliferative pathways in CD1- CD3+ CD4+ CD8+ T-prolymphocytic leukemic cells: analysis with monoclonal antibodies and cytokines
- Author
-
Turco, MC, De Felice, M, Alfinito, F, Lamberti, A, Costanzo, F, Giordano, M, Martinelli, V, Rotoli, B, Ferrone, S, and Venuta, S
- Abstract
The antigenic profile and the proliferative pathways in leukemic cells from the patient TRT with T-prolymphocytic leukemia (T-PLL) were analyzed using monoclonal antibodies (MoAbs) and cytokines. T-PLL cells expressed the phenotype CD1- CD3+ CD4+ CD8+. Incubation with the differentiating agent phorbol-12-myristate-13-acetate markedly increased the percentage of cells with the CD4- CD8+ phenotype, suggesting that leukemic cells were already committed towards a differentiated element with the CD4- CD8+ phenotype. T-PLL cells were induced to proliferate by anti-CD2 MoAb 9–1 + 9.6 and by anti-CD3 MoAb OKT3. The two pathways exhibited normal functional interactions and were susceptible to modulation by anti-HLA class I MoAbs. These results indicate that regulation of cell proliferation was preserved to a significant extent in the T-PLL cells analyzed. At variance with normal resting T cells that require previous activation to proliferate when incubated with interleukin-1 (IL-1) or interleukin-2 (IL-2), T-PLL cells proliferated vigorously when incubated with either interleukin. Furthermore, T-PLL cells proliferated when incubated with immune interferon (IFN-gamma). The latter finding parallels the enhancement by IFN-gamma of the proliferative response of lectin-activated murine T lymphocytes. These results suggest that T-PLL cells, which express a high constitutive level of c-myc mRNA, may be in an activated state. The antigenic phenotype and the characteristics of the proliferative pathways of T-PLL cells from the patient TRT are compatible with the possibility that they may be derived from an intermediate thymocyte.
- Published
- 1989
- Full Text
- View/download PDF
5. Single and multiple muon events in the LVD detector
- Author
-
Anzivino, G., Bianco, S., Casaccia, R., Cindolo, F., De Felice, M., Enorini, M., Fabbri, F.L., Laakso, I., Pallante, E., Susinno, G., Votano, L., Zallo, A., Bari, G., Basile, M., Bruni, G., Cara Romeo, G., Cifarelli, L., Contin, A., Del Papa, C., Giusti, P., Iacobucci, G., Maccarrone, G., Massam, T., Nania, R., Sartorelli, G., D'Ali, G., and Zichichi, A.
- Abstract
Expected rates of deep-underground muons in the LVD detector, at a vertical depth of 3600 hg/cm2s.r. (standard rock) at the Gran Sasso, were obtained through Monte Carlo simulation. Two different generators were developed to reproduce single and multiple muon distributions at our detector level. The main purpose was to evaluate the potentiality of the apparatus in studying chemical composition and energy spectra of primary cosmic rays in the range 1014–1016eV through the detection of muon bundles of high multiplicity. Sensitivity of the detector was checked by comparing event-rate predictions for three different models of the primary composition: the Maryland spectrum, the “low energy composition” model, and the NUSEX parametrization (with spectral index of iron γFe= 2.60 and 2.70). We predict a single muon rate in the apparatus of about 3.26×106events/year. Preliminary results for multiple muon-event detection show that we can separate with a good sensitivity different primary compositions in the multiplicity region around n= 10.
- Published
- 1990
- Full Text
- View/download PDF
6. T-cell malignancies with mature phenotypes: altered cell cycle regulation by HLA class I molecules
- Author
-
Turco, MC, Alfinito, F, De Felice, M, Lamberti, A, Ferrone, S, and Venuta, S
- Abstract
Soluble anti-HLA class I monoclonal antibodies (MoAbs) modulate normal T-lymphocyte proliferation induced via the CD3/Ti and the CD2 pathway, but do not induce proliferation of normal T lymphocytes in the absence of additional mitogenic stimuli. In this report, we show that anti-HLA class I MoAbs induce DNA synthesis in peripheral blood mononuclear cells from a patient with a CD4+CD8+T-prolymphocytic leukemia (T-PLL) and from a patient with a CD4-CD8+ T-chronic lymphocytic leukemia (T- CLL), in the absence of detectable additional mitogenic stimuli. Proliferation of leukemic T cells is induced by both whole Igs and Fab' fragments of anti-HLA class I MoAbs, arguing in favor of their direct interactions with the proliferating cells as the mechanism underlying the mitogenic effect. This interpretation is also supported by the ability of anti-HLA class I MoAbs to induce proliferation of leukemic T- cell preparations, depleted of accessory cells. DNA synthesis in T-CLL and T-PLL cells is preceded by expression of G1-specific messenger RNAs, ie. c-myc, 2F1, Tac, and interferon-gamma, in activated cells. Cell proliferation is inhibited by the protein kinase C inhibitor H7, indicating that activation of this enzyme is required for the mitogenic effect of anti-HLA class I MoAbs. The latter inhibit the proliferation of T-CLL cells as well as that of normal T cells stimulated with anti- CD3 MoAbs and enhance that of both types of cells stimulated with anti- CD2 MoAbs. In addition, anti-HLA class I MoAb Q6/64 in combination with anti-CD2 MoAb 9.6 or MoAb 9–1 induces proliferation of leukemic T cells to a greater extent than the individual MoAbs, but is not mitogenic for normal T cells. Anti-HLA class I MoAbs restore the cytolytic activity of T-CLL cells that is lost after 5 days of incubation of control medium, suggesting that HLA class I antigens may mediate a signal contributing to the activation state. The present results indicate that leukemic T-cell proliferation can be triggered via HLA class I molecules and suggest a potential role for these antigens in the in vivo growth of malignant clones.
- Published
- 1991
- Full Text
- View/download PDF
7. Mapping and functional role of phosphorylation sites in the thyroid transcription factor-1 (TTF-1).
- Author
-
Zannini, M, Acebron, A, De Felice, M, Arnone, M I, Martin-Pérez, J, Santisteban, P, and Di Lauro, R
- Abstract
The phosphorylation of thyroid transcription factor-1 (TTF-1), is homeodomain-containing transcription factor that is required for thyroid-specific expression of the thyroglobulin and thyroperoxidase gene promoters, has been studied. Phosphorylation occurs on a maximum of seven serine residues that are distributed in three tryptic peptides. Mutant derivatives of TTF-1, with alanine sites, have been constructed and used to assess the functional relevance of TTF-1 phosphorylation. The DNA binding activity of TTF-1 appears to be phosphorylation-independent, as indicated also by the performance of TTF-1 purified from an overexpressing Escherichia coli strain. Transcriptional activation by TTF-1 could require phosphorylation only in specific cell types since in a co-transfection assay in heterologous cells both wild-type and mutant proteins show a similar transcriptional activity.
- Published
- 1996
8. Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1.
- Author
-
De Felice, M, Damante, G, Zannini, M, Francis-Lang, H, and Di Lauro, R
- Abstract
The thyroid transcription factor 1 (TTF-1) is a homeodomain-containing protein implicated in the activation of thyroid-specific gene expression. Here we report that TTF-1 is capable of activating transcription from thyroglobulin and, to a lesser extent, thyroperoxidase gene promoters in nonthyroid cells. Full transcriptional activation of the thyroglobulin promoter by TTF-1 requires the presence of at least two TTF-1 binding sites. TTF-1 activates transcription via two functionally redundant transcriptional activation domains that as suggested by competition experiments, could use a common intermediary factor.
- Published
- 1995
9. Proliferative Pathways in CD1-CD3+CD4+CD8+T-Prolymphocytic Leukemic Cells: Analysis With Monoclonal Antibodies and Cytokines
- Author
-
Turco, M.C., De Felice, M., Alfinito, F., Lamberti, A., Costanzo, F., Giordano, M., Martinelli, V., Rotoli, B., Ferrone, S., and Venuta, S.
- Abstract
The antigenic profile and the proliferative pathways in leukemic cells from the patient TRT with T-prolymphocytic leukemia (T-PLL) were analyzed using monoclonal antibodies (MoAbs) and cytokines. T-PLL cells expressed the phenotype CD1-CD3+CD4+CD8\ Incubation with the differentiating agent phorbol-12-myristate-13-acetate markedly increased the percentage of cells with the CD4 CD8+phenotype, suggesting that leukemic cells were already committed towards a differentiated element with the CD4 CD8+phenotype. T-PLL cells were induced to proliferate by anti-CD2 MoAb 9-1+9.6 and by anti-CD3 MoAb OKT3. The two pathways exhibited normal functional interactions and were susceptible to modulation by anti-HLA class I MoAbs. These results indicate that regulation of cell proliferation was preserved to a significant extent in the T-PLL cells analyzed. At variance with normal resting T cells that require previous activation to proliferate when incubated with interleukin-1 (IL-1) or interleukin-2 (IL-2), T-PLL cells proliferated vigorously when incubated with either interleukin. Furthermore, T-PLL cells proliferated when incubated with immune interferon (IFN- γ). The latter finding parallels the enhancement by IFN- γof the proliferative response of lectin-activated murine T lymphocytes. These results suggest that T-PLL cells, which express a high constitutive level of c-mycmRNA, may be in an activated state. The antigenic phenotype and the characteristics of the proliferative pathways of T-PLL cells from the patient TRT are compatible with the possibility that they may be derived from an intermediate thymocyte. © 1989 by Grune & Stratton. Inc.
- Published
- 1989
- Full Text
- View/download PDF
10. Unusual organization of the ilvIH promoter of Escherichia coli
- Author
-
Haughn, G W, Squires, C H, De Felice, M, Largo, C T, and Calvo, J M
- Abstract
Analysis of plasmids containing ilvIH-galK fusions indicated that the Escherichia coli ilvIH promoter and sequences sufficient to cause leucine repression lie within 363 base pairs (bp) of ilvI. Experiments designed to locate the promoter and regulatory sequences more precisely gave the following results. The positions of the 5' endpoints of both unlabeled and pulse-labeled ilvIH mRNAs transcribed in vivo lie 30 bp upstream of ilvI. By contrast, the major in vitro RNA endpoints lie at positions further upstream. Several mutations which increase the expression of ilvIH lie 40 to 50 bp upstream of ilvI, within a putative promoter termed P1. Deletion of a 50-bp region immediately upstream of ilvI, which includes P1, resulted in the loss of all ilvIH promoter activity. Deletion of sequences more than 200 bp upstream of ilvI reduced ilvIH promoter activity by more than 80%. These results suggest that transcription of the ilvIH operon is initiated from promoter P1 but that sequences more than 200 bp upstream are required for optimal transcription of the operon.
- Published
- 1985
- Full Text
- View/download PDF
11. Multiple mechanisms of interference between transformation and differentiation in thyroid cells
- Author
-
Francis-Lang, H, Zannini, M, De Felice, M, Berlingieri, M T, Fusco, A, and Di Lauro, R
- Abstract
Transformation of the thyroid cell line FRTL-5 results in loss or reduction of differentiation as measured by the expression of thyroglobulin and thyroperoxidase, two proteins whose genes are exclusively expressed in thyroid follicular cells. The biochemical mechanisms leading to this phenomenon were investigated in three cell lines obtained by transformation of FRTL-5 cells with Ki-ras, Ha-ras, and polyomavirus middle-T oncogenes. With the ras oncogenes, transformation leads to undetectable expression of the thyroglobulin and thyroperoxidase genes. However, the mechanisms responsible for the extinction of the differentiated phenotype seem to be different for the two ras oncogenes. In Ki-ras-transformed cells, the mRNA encoding TTF-1, a transcription factor controlling thyroglobulin and thyroperoxidase gene expression, is severely reduced. On the contrary, nearly wild-type levels of TTF-1 mRNA are detected in Ha-ras-transformed cells. Furthermore, overexpression of TTF-1 can activate transcription of the thyroglobulin promoter in Ki-ras-transformed cells, whereas it has no effect on thyroglobulin transcription in the Ha-ras-transformed line. Expression of polyoma middle-T antigen in thyroid cells leads to only a reduction of differentiation and does not severely affect either the activity or the amount of TTF-1. Another thyroid cell-specific transcription factor, TTF-2, is more sensitive to transformation, since it disappears in all three transformed lines, and probably contributes to the reduced expression of the differentiated phenotype.
- Published
- 1992
- Full Text
- View/download PDF
12. Physical characterization of the ilvHI operon of Escherichia coli K-12
- Author
-
Squires, C H, De Felice, M, Wessler, S R, and Calvo, J M
- Abstract
The ilvHI and leu genes of Escherichia coli K-12 are contained on a single 10.9-kilobase EcoRI fragment of deoxyribonucleic acid derived from the leu transducing phage lambda G4. Since the expression of all of these genes is controlled by leucine, we investigated whether they are part of single operon or whether they constitute separate but adjacent operons controlled from a common site. Both cloning and hybridization studies indicated that ilvHI and leu are distinct operons. They are transcribed in opposite directions and are separated by approximately 1,500 base pairs of deoxyribonucleic acid. Hybridization experiments showed that the expression of ilvHI is regulated chiefly at the level of transcription. The size of the ilvHI messenger ribonucleic acid is estimated to be 2,550 bases.
- Published
- 1981
- Full Text
- View/download PDF
13. Enhanced acetohydroxy acid synthase III activity in an ilvH mutant of Escherichia coli K-12
- Author
-
Ricca, E, Limauro, D, Lago, C T, and de Felice, M
- Abstract
The acetohydroxy acid synthase III isozyme, which catalyzes the first common step in the biosynthesis of isoleucine, leucine, and valine in Escherichia coli K-12, is composed of two subunits, the ilvI and ilvH gene products. A missense mutation in ilvH (ilvH612), which reduced the sensitivity of the enzyme to the end product inhibition by valine, also increased its specific activity and lowered the Km for alpha-acetolactate synthesis. The mutation increased the sensitivity of acetohydroxy acid synthase III to dialysis and heat treatment and reduced the requirement for thiamine pyrophosphate addition to the assay mixture for activity. A strain carrying the ilvH612 mutation grew better than a homologous ilvH+ strain in the presence of leucine. The data indicate that this is a consequence of a more active acetohydroxy acid synthase III isozyme rather than the result of an alteration of the leucine-mediated repression of the ilvIH operon.
- Published
- 1988
- Full Text
- View/download PDF
14. HLA AND CONGENITAL ADRENAL HYPERPLASIA
- Author
-
Zappacosta, S., De Felice, M., Minozzi, M., Lombardi, G., Valentino, Rossella, Vanacore, Giuseppina, Murtaza, L.M., Hughes, I.A., Sibert, J.R., and Balfour, I.C.
- Published
- 1978
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.